APEXBIO

LIVE

Serial Number

88590882

Owner

APEX BIOTECHNOLOGY CORPORATION

Attorney

Jeannine Rittenhouse

First Use Date

Nov 13, 2017

Filing Date

Aug 23, 2019

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

APEXBIO Trademark

Serial Number: 88590882 • Registration: 6081902

APEXBIO is a trademark filed by APEX BIOTECHNOLOGY CORPORATION on August 23, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 10 - Medical Apparatus

Surgical, medical, dental and veterinary apparatus and instruments

Owner Contact Info

APEX BIOTECHNOLOGY CORPORATION (7 trademarks)

No. 7
Hsinchu City 30078 , TW

Entity Type: 03

Legal Representation

Attorney of Record

Jeannine Rittenhouse

1,247 trademarks filed View all →

Correspondence Address

Jeannine Rittenhouse IPHORGAN LTD.

195 ARLINGTON HEIGHTS ROAD, SUITE 125

BUFFALO GROVE, IL 60089

United States

Trademark Details

Filing Date

August 23, 2019

Registration Date

June 16, 2020

First Use Anywhere

November 13, 2017

First Use in Commerce

April 3, 2020

Published for Opposition

February 25, 2020

Goods & Services

Testing and analytical apparatus for medical diagnostic use in the field of blood biochemistry; testing and analytical apparatus for medical diagnostic use in the field of urine biochemistry; blood uric monitoring apparatus for medical diagnostic use; blood glucose monitoring apparatus for medical use; lancets; hemoglobin testing apparatus for medical diagnostic use; cholesterol testing apparatus for medical diagnostic use; lactic acid testing apparatus for medical diagnostic use

Reagent strips for medical diagnostic use; glucose control solution for medical diagnostic use; uric acid control solution for medical diagnostic use; hemoglobin testing agents for medical diagnostic use; cholesterol testing agents for medical diagnostic use; lactic acid testing agents for medical diagnostic use

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Dec 15, 2025 NA85

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Dec 15, 2025 C15A

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Dec 15, 2025 APRE

TEAS SECTION 8 & 15 RECEIVED

Sep 10, 2025 E815

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jun 16, 2025 REM1

REGISTERED-PRINCIPAL REGISTER

Jun 16, 2020 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

May 15, 2020 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

May 14, 2020 CNPR

STATEMENT OF USE PROCESSING COMPLETE

May 12, 2020 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

May 11, 2020 AITU

USE AMENDMENT FILED

Apr 27, 2020 IUAF

TEAS STATEMENT OF USE RECEIVED

Apr 27, 2020 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 21, 2020 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 25, 2020 NPUB

PUBLISHED FOR OPPOSITION

Feb 25, 2020 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 5, 2020 NONP

ASSIGNED TO LIE

Jan 21, 2020 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 17, 2020 CNSA

EXAMINER'S AMENDMENT ENTERED

Jan 17, 2020 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jan 17, 2020 GNEN

EXAMINERS AMENDMENT E-MAILED

Jan 17, 2020 GNEA

EXAMINERS AMENDMENT -WRITTEN

Jan 17, 2020 CNEA

NOTIFICATION OF PRIORITY ACTION E-MAILED

Dec 2, 2019 GPRN

PRIORITY ACTION E-MAILED

Dec 2, 2019 GPRA

PRIORITY ACTION WRITTEN

Dec 2, 2019 CPRA

ASSIGNED TO EXAMINER

Nov 22, 2019 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 7, 2019 NWOS

NEW APPLICATION ENTERED

Aug 27, 2019 NWAP

Related Trademarks

More from this Owner

APEXBIO

More in Same Class